British journal of clinical pharmacology
Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England.
Louis Fisher, Richard Buka, Rosalind Byrne, Stephen Black, Helen J Curtis, Christopher Wood, Andrew Brown, Sebastian Bacon, Richard Croker, Ben Goldacre, Brian MacKenna, Victoria Speed
Published: 202510.1002/bcp.70417
Abstract
AIMS: Andexanet alfa was recommended by the National Institute for Health and Clinical Excellence (NICE) as an option in the management of life-threatening gastrointestinal bleeding in patients taking apixaban or rivaroxaban in May 2021. A recent UK-…
Preview only. Read the full abstract at the source